Immunic, inc. to participate in industry and investor conferences in june

New york, june 10, 2021 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced participation in the following industry and investor conferences in june: june 14-18: bio digital (formerly bio international convention). members of the company's business development team will host one-on-one partnering meetings during the conference.
IMUX Ratings Summary
IMUX Quant Ranking